Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-05

Clinical Trial Update: Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra® & Compare Both to a Vehicle Control in Treatment of Interdigital Tinea Pedis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and bioequivalence of a generic butenafine cream and Lotrimin Ultra compared with a vehicle in interdigital tinea pedis; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Generic Butenafine Cream (butenafine)
  • Lotrimin Ultra (butenafine)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Tinea Pedis | Phase 1 | Status: COMPLETED